Results     22-May-24
Announcements
Strides Pharma Science reports consolidated net profit of Rs 18.18 crore in the March 2024 quarter
Sales rise 9.90% to Rs 1084.04 crore
Net profit of Strides Pharma Science reported to Rs 18.18 crore in the quarter ended March 2024 as against net loss of Rs 9.54 crore during the previous quarter ended March 2023. Sales rose 9.90% to Rs 1084.04 crore in the quarter ended March 2024 as against Rs 986.37 crore during the previous quarter ended March 2023.

For the full year,net loss reported to Rs 70.61 crore in the year ended March 2024 as against net loss of Rs 202.64 crore during the previous year ended March 2023. Sales rose 9.83% to Rs 4051.12 crore in the year ended March 2024 as against Rs 3688.39 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales1084.04986.37 10 4051.123688.39 10
OPM %16.7111.65 -14.013.93 -
PBDT87.4561.56 42 292.79-25.92 LP
PBT37.690.63 5883 72.11-269.17 LP
NP18.18-9.54 LP -70.61-202.64 65

Previous News
  Strides Pharma hits record high after arm gets USFDA nod for antidepressant drug
 ( Hot Pursuit - 16-Sep-24   15:53 )
  Strides receives USFDA approval for Fluoxetine Tabs 60 mg
 ( Corporate News - 16-Sep-24   15:22 )
  Strides secures approval of shareholders and creditors for creation of OneSource
 ( Corporate News - 11-Sep-24   14:48 )
  Strides Pharma Science schedules AGM
 ( Corporate News - 06-Sep-24   16:39 )
  Strides Pharma hits record high as arm gets USFDA nod for asthma drug
 ( Hot Pursuit - 06-Sep-24   10:45 )
  Strides Pharma Science receives USFDA approval for generic version of Theophylline ER Tablets 300 mg and 540 mg
 ( Corporate News - 06-Sep-24   10:17 )
  Strides Pharma Science fixes record date for final dividend
 ( Market Beat - Reports 22-Aug-24   15:57 )
  Nifty above 24,550 mark; broader mkt outperforms
 ( Market Commentary - Mid-Session 19-Aug-24   13:30 )
  Barometers trade sideways; Oil & gas shares advance
 ( Market Commentary - Mid-Session 19-Aug-24   12:40 )
  Strides Pharma arm gets EIR from USFDA for Chennai facility
 ( Hot Pursuit - 19-Aug-24   11:20 )
  Strides Alathur successfully concludes USFDA inspection
 ( Corporate News - 19-Aug-24   11:17 )
Other Stories
  Shri Bholanath Carpets reports standalone net profit of Rs 0.02 crore in the June 2024 quarter
  30-Sep-24   07:34
  Gala Precision Engineering consolidated net profit rises 38.55% in the June 2024 quarter
  30-Sep-24   07:34
  Kross standalone net profit declines 4.25% in the June 2024 quarter
  28-Sep-24   07:36
  Jamna Auto Industries consolidated net profit rises 1.73% in the June 2024 quarter
  28-Sep-24   07:35
  Baazar Style Retail reports standalone net loss of Rs 0.39 crore in the June 2024 quarter
  26-Sep-24   07:35
  Mysore Paper Mills reports standalone net loss of Rs 22.19 crore in the June 2024 quarter
  26-Sep-24   07:35
  Educomp Solutions reports standalone net loss of Rs 1.81 crore in the June 2024 quarter
  25-Sep-24   07:30
  Ecos (India) Mobility & Hospitality consolidated net profit declines 3.08% in the June 2024 quarter
  25-Sep-24   07:30
  Orissa Minerals Development Company reports standalone net loss of Rs 2.08 crore in the June 2024 quarter
  24-Sep-24   07:43
  Apis India consolidated net profit declines 40.92% in the June 2024 quarter
  21-Sep-24   07:30
Back Top